Home › Merck Begins Tender Offer to Acquire Idenix
 

Keywords :   


Merck Begins Tender Offer to Acquire Idenix

2014-06-20 13:30:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX). On June 09, 2014, Merck announced its intent to acquire Idenix. Language: English Contact: Media:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461Investors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: offer begins acquire tender

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 12
More »